Literature DB >> 3304614

The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma.

R A Badalament, D K Hermansen, M Kimmel, H Gay, H W Herr, W R Fair, W F Whitmore, M R Melamed.   

Abstract

The sensitivity of voided urinary cytology (VUC), bladder wash cytology (BWC), and bladder wash flow cytometry (BWFCM) in detecting cancer was studied in 70 patients with biopsy-proven bladder tumors. There were 11 Grade I papillomas, 14 Grade II TA, 18 Grade II-III TIS, 19 Grade II-III T1, and eight Grade II-III T2 carcinomas. One to five VUCs per patient (mean, 2.63) were obtained within the 24 hours preceding biopsy. At endoscopy a bladder wash specimen was obtained and divided for cytologic and flow cytometric examinations. For all tumor categories combined, the sensitivity for one, two, and three voided cytology examinations per patient was 41%, 41%, and 60%, respectively. The sensitivity of a single BWC was 61%, of a single BWFCM, 83%. Thus, one BWFCM is more sensitive than three VUC (binomial test; P = 0.006); one BWC is more sensitive than two VUC (P = 0.01); and one BWFCM is more sensitive than one BWC (P = 0.003). These findings remain significant when papillomas are excluded from the analysis (P less than or equal to 0.03) and when papillomas and T2 tumors are jointly excluded (P less than or equal to 0.02). Only four of 70 patients (6%) had their cancers detected by VUC and/or BWC rather than BWFCM. In summary, irrigation cytology specimens are more sensitive than voided urinary cytology, and bladder wash flow cytometry is more sensitive than either in diagnosing bladder cancer. Flow cytometry is more sensitive because of the better sampling of bladder irrigation compared with voided urine and because of the measurement technique itself.

Entities:  

Mesh:

Year:  1987        PMID: 3304614     DOI: 10.1002/1097-0142(19871001)60:7<1423::aid-cncr2820600702>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  22 in total

1.  Transurethral ultrasonography, fiberoptic cystoscopy and bladder washout cytology in the evaluation of bladder tumours.

Authors:  A Akdaş; L Türkeri; D Ersev; A Ersev; S Kullu
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

2.  Detecting bladder cancer.

Authors:  R Plail
Journal:  BMJ       Date:  1990-09-22

3.  Low utility of CYFRA 21-1 serum levels for diagnosis and follow-up in bladder cancer patients.

Authors:  Daniel Fatela-Cantillo; Antonio Fernández-Suárez; Violeta Menéndez; Juan Antonio Galán; Xavier Filella
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

Review 4.  Urothelial carcinoma of the bladder: definition, treatment and future efforts.

Authors:  Sandip M Prasad; G Joel Decastro; Gary D Steinberg
Journal:  Nat Rev Urol       Date:  2011-10-11       Impact factor: 14.432

5.  Using urine microscopy and cytology for early detection of bladder cancer in male patients with lower urinary tract symptoms.

Authors:  Eddie S Y Chan; Chi-Fai Ng; See-Ming Hou; Sidney K H Yip
Journal:  Int Urol Nephrol       Date:  2010-11-04       Impact factor: 2.370

Review 6.  The role of nuclear matrix protein 22 in the detection of persistent or recurrent transitional-cell cancer of the bladder.

Authors:  S W Shelfo; M S Soloway
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

7.  Spectrophotometric photodynamic detection involving extracorporeal treatment with hexaminolevulinate for bladder cancer cells in voided urine.

Authors:  Yasushi Nakai; Toshiyuki Ozawa; Fumiko Mizuno; Sayuri Onishi; Takuya Owari; Syunta Hori; Yosuke Morizawa; Yosihiro Tatsumi; Makito Miyake; Nobumichi Tanaka; Daisuke Tsuruta; Kiyohide Fujimoto
Journal:  J Cancer Res Clin Oncol       Date:  2017-07-19       Impact factor: 4.553

8.  Comparison of the nuclear matrix protein 22 with voided urine cytology in the diagnosis of transitional cell carcinoma of the bladder.

Authors:  Murat Lekili; Ercüment Sener; Mehmet Akif Demir; Gökhan Temeltaş; Talha Müezzinoğlu; Coşkun Büyüksu
Journal:  Urol Res       Date:  2003-12-19

9.  Flow cytometry versus urinary cytology in the diagnosis and follow-up of bladder tumors: critical review of a 5-year experience.

Authors:  C Billerey; B Lamy; H Bittard; S Rozan; J P Carbillet
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

Review 10.  Bladder tumor markers: from hematuria to molecular diagnostics--where do we stand?

Authors:  Samir P Shirodkar; Vinata B Lokeshwar
Journal:  Expert Rev Anticancer Ther       Date:  2008-07       Impact factor: 4.512

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.